The global market size has been evaluated at USD 3.31 billion in 2025 and it is expected to be worth around USD 170 billion ...
In collaboration with the Paul-Ehrlich-Institute and the German Center for Infection Research, the company is now using its immuno-oncology technology to develop a measles-vectored COVID-19 ...